When Shacey Petrovic stepped down as CEO of Acton medical-device company Insulet in May for personal reasons, she left Central Massachusetts without a single public company headquartered here, traded on NASDAQ or New York Stock Exchange, with a woman as CEO.
Petrovic left her CEO position to deal with a family medical issue, but remained on the company’s board and will continue with the company as an advisor through May 2023.
Jim Hollingshead succeeded Petrovic as CEO on June 1. Hollingshead had been a member of the Insulet board of directors since 2019 and was most recently the president of the sleep and respiratory care business at ResMed Inc. in San Diego.
Insulet announced the CEO transition in a May 5 press release to the public and its investors. WBJ came across this news in late August while pursuing another story about Insulet.
Petrovic’s resignation means none of the 15 publicly traded companies headquartered in Central Massachusetts have a female CEO. Public companies are among the largest and most visible businesses in the region, including some with annual revenues in the billions of dollars, and because they are publicly traded have to divulge more information about their operations, including the makeup of their executive teams and their salaries.
Other than Insulet, the other Central Massachusetts public companies are:
- Ameresco, Inc. of Framingham
- American Superconductor Corp. of Ayer
- Boston Scientific Corp. of Marlborough
- BJ’s Wholesale Club, Inc. of Westborough
- Cognex Corp. of Natick
- Cytiva of MarlboroughÂ
- The Hanover Insurance Group, Inc. of Worcester
- Hologic, Inc. of Marlborough
- IPG Photonics Corp. of Oxford
- The L.S. Starrett Co. of Athol
- Psychemedics Corp. of Acton
- ReWalk Robotics, Inc. of Marlborough
- TJX Cos., Inc. of Framingham
- Waters Corp. of Milford
